Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check2 days agoChange DetectedIntroduces a recruitment notice and new navigation aids to help users understand and join the study; includes a minor formatting change to the Intervention header and a new revision tag (v3.6.0).SummaryDifference0.4%

- Check9 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a new build/version of the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag has been updated to v3.5.4, replacing v3.5.3, signaling a minor update to the page version.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows an updated “Revision” identifier for the ClinicalTrials.gov interface (v3.5.3 instead of v3.5.2), reflecting a software/content template update rather than a change to the clinical study details.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check88 days agoChange Detected- Revision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3 on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.